IONS · Company research
Ionis Pharmaceuticals, Inc. Common Stock (IONS): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 44.16 | $7,538,143,830 | 7188078830.00 | 23.8315789473684211 | — | — | 28.1327559722185938 | 17.1423915431269145 | 13.7194105206833730 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.